Drug recall · August 7, 2019
Drospirenone and Ethinyl Estradiol Tablets recall
Why: Failed dissolution specifications : failed results at the 3-month stability time point.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each blister card contains 28-film coated, biconvex tablets, Rx Only, Manufactured by: Cyndea Pharma, S.L., Olvega (Soria), 42110 Spain, Distributed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801 USA, NDC 59746-763-43
- Lots / codes
Lot #: 183222, Exp 11/2020
- Quantity
- 11,412 cartons/34,236 blister cards/28 tablets each card
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- USA Nationwide
- Initiated
- July 9, 2019 · Voluntary: Firm initiated
- Classified
- August 19, 2019
- Reported
- August 7, 2019
- Ended
- May 7, 2021
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.